Retractable Technologies (RVP) Operating Expenses (2010 - 2026)
Retractable Technologies' (RVP) quarterly Operating Expenses came in at $5.3 million in Q2 2026, up 6.23% on a YoY basis from $5.0 million in Q2 2025, and little changed quarter-over-quarter from $5.3 million in Q1 2026.
Analysis
Retractable Technologies (RVP) Operating Expenses (2010 - 2026) Analysis & Trends
Retractable Technologies (RVP) has reported Operating Expenses for 17 consecutive years, with $5.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Operating Expenses rose 6.23% year-over-year to $5.3 million; the trailing twelve-month figure through Jun 2026 stood at $22.2 million (up 13.53% YoY), and the FY2025 full-year result was $21.2 million, up 5.7% from the prior year.
- Operating Expenses steadied at $5.3 million in Q2 2026 per RVP's latest filing, from $5.3 million in the prior quarter.
- Across five years, Operating Expenses topped out at $12.1 million in Q4 2022 and bottomed at $4.3 million in Q4 2023.
- Historically, Operating Expenses has averaged $5.6 million across 5 years, with a median of $5.3 million in 2025.
- The sharpest annual moves came in 2022 and 2023: Operating Expenses jumped 109.62% in 2022, then sank 64.38% in 2023.
- Over 5 years, Operating Expenses stood at $12.1 million in 2022, then plunged by 64.38% to $4.3 million in 2023, then rose by 9.41% to $4.7 million in 2024, then soared by 30.83% to $6.2 million in 2025, then dropped by 13.7% to $5.3 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $5.3 million, $5.3 million, and $6.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 48.31 Bn | 47.45 Bn | 2.32 Bn | 4.32 Bn |
| 2 | Medline | 28.02 Bn | 25.35 Bn | 2.22 Bn | 1.82 Bn |
| 3 | West Pharmaceutical Services | 24.18 Bn | 23.75 Bn | 329.20 Mn | 137.30 Mn |
| 4 | Baxter International | 12.44 Bn | 10.29 Bn | 1.03 Bn | 864.00 Mn |
| 5 | Stevanato Group S.p.A | 5.69 Bn | 5.58 Bn | 100.91 Mn | 34.66 Mn |
| 6 | Acme United | 235.50 Mn | 230.46 Mn | 26.69 Mn | 19.86 Mn |
| 7 | Rockwell Medical | 30.24 Mn | 5.45 Mn | 3.24 Mn | 4.26 Mn |
| 8 | Retractable Technologies | 21.15 Mn | -18.72 Mn | 190,852.00 | 5.34 Mn |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - | 166,850.00 |
| 10 | Cuprina Holdings (Cayman) | 7.88 Mn | 4.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.34 Mn |
| Mar 31, 2026 | 5.33 Mn |
| Dec 31, 2025 | 6.18 Mn |
| Sep 30, 2025 | 5.34 Mn |
| Jun 30, 2025 | 5.02 Mn |
| Mar 31, 2025 | 4.67 Mn |
| Dec 31, 2024 | 4.73 Mn |
| Sep 30, 2024 | 5.12 Mn |
| Jun 30, 2024 | 5.34 Mn |
| Mar 31, 2024 | 4.89 Mn |
| Dec 31, 2023 | 4.32 Mn |
| Sep 30, 2023 | 5.26 Mn |
| Jun 30, 2023 | 5.41 Mn |
| Mar 31, 2023 | 5.61 Mn |
| Dec 31, 2022 | 12.13 Mn |
| Sep 30, 2022 | 5.43 Mn |
| Jun 30, 2022 | 5.71 Mn |
| Mar 31, 2022 | 5.84 Mn |
| Dec 31, 2021 | 5.79 Mn |
| Sep 30, 2021 | 5.43 Mn |